The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

The FTC study examines the practices of PBMs to ensure fair competition and transparency. The FTC found that from 2017 to 2022, the three big PBMs imposed substantial price markups on 51 specialty ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes a similar attack on the drug middlemen ...

Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations that negotiate access to medicines for most patients in the United States—steer patients to use their ...

Multiple reports indicate that employers can expect rising healthcare costs in 2025. To address these costs, employers are ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

With multiple stakeholders involved with different interests, the “specialty drug” definition can be a moving target.

As someone who has lived with multiple chronic conditions, including cancer, arthritis, and lupus, and spent my career as a nurse, I know firsthand how dangerous not being able to access a prescribed ...

Fujifilm's Irvine Scientific unit has licensed rights to an artificial intelligence-powered technology developed to improve the success rate of in vitro fertilisation (IVF) techniques. The cell ...